Boehringer Ingelheim Launches Trivalent Poultry Vaccine to Combat Major Diseases in Egypt
Boehringer Ingelheim will launch its trivalent vaccine VAXXITEK® HVT+IBD+H5 in February 2025, providing crucial protection against Marek’s disease, Infectious Bursal...